For the period (end-January 31), the Chatsworth, CA-based radiation therapy developer had revenues of $7.6 million, up slightly from the $7.5 million posted a year ago. The firm had a net loss of $3.2 million, compared with a net loss of $2.7 million in the fiscal first quarter of 2006.
In other developments, NAS said that it's on track to sell its first ClearPath breast brachytherapy products in the second quarter.
By AuntMinnie.com staff writers
March 15, 2007
NAS trims year-end losses, January 12, 2007
NAS receives 510(k) for ClearPath, November 14, 2006
North American Scientific unveils ClearPath, November 8, 2006
Cutrer to step down as NAS president/CEO, November 3, 2006
NAS gets nomosSTAT install, October 19, 2006
Copyright © 2007 AuntMinnie.com